Insomnia News and Research

Latest Insomnia News and Research

Researchers make first link between menopause, smoking and genetic variations in white women

New research is lighting up yet another reason for women to quit smoking. In a study published online in the journal Menopause, researchers from the Perelman School of Medicine at the University of Pennsylvania report the first evidence showing that smoking causes earlier signs of menopause - in the case of heavy smokers, up to nine years earlier than average - in white women with certain genetic variations.

5 Feb 2014

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has executed two agreements; with Ildong Pharmaceuticals Co Ltd, Korea and Ergomed Clinical Research Ltd, UK to support further clinical studies of Lorediplon in patients with insomnia.

3 Feb 2014

More than 1/3 of women experience hot flashes for 10 years after menopause

A team of researchers from the Perelman School of Medicine at the University of Pennsylvania has found that moderate to severe hot flashes continue, on average, for nearly five years after menopause, and more than a third of women experience moderate/severe hot flashes for 10 years or more after menopause.

31 Jan 2014

REM sleep, memory and depression: an interview with Dr Penny Lewis, University of Manchester

Usually you don’t go into REM until you’ve passed through all the other stages of sleep. The stage immediately before REM is slow-wave sleep.

From The University of Manchester 29 Jan 2014

Study outlines agenda to help direct future caffeine dependence research

"I'm a zombie without my morning coffee." "My blood type is Diet Coke." "Caffeine isn't a drug, it's a vitamin." Most people make jokes like these about needing a daily boost from their favorite caffeinated beverage-whether first thing in the morning or to prevent the after-lunch slump.

29 Jan 2014

Study: Nightmares have greater emotional impact than bad dreams do

According to a new study by researchers at the University of Montreal, nightmares have greater emotional impact than bad dreams do, and fear is not always a factor. In fact, it is mostly absent in bad dreams and in a third of nightmares.

28 Jan 2014

Acute to chronic insomnia transition warns of depression risk

In patients with acute insomnia, long periods of light sleep may be the key driver to chronic insomnia and depression, research suggests.

27 Jan 2014

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

A new study published in the Journal of Urology- reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment.

24 Jan 2014

Proper good night's sleep promotes both mental and physical health

Getting a good night's sleep means more than you probably think. "I would say the importance of sleep is definitely underestimated by the general public," said Dr. Sandhya Kumar, assistant professor of neurology at Wake Forest Baptist Medical Center and medical director of its Sleep Center.

23 Jan 2014

Targeting symptoms, rather than disorders, might help reduce work impact of mental health issues

Symptoms such as insomnia and emotional distress account for much of the work impact of mental health problems such as depression and anxiety, reports a study in the February issue of Medical Care.

23 Jan 2014

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

ViiV Healthcare today announced that the European Commission has approved Tivicay (dolutegravir), an integrase inhibitor, for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

21 Jan 2014

Technology increases cognitive behavioral therapy options for insomnia

Web- and telehealth-based delivery of cognitive behavioral therapy is effective for treating chronic insomnia, giving rural-dwelling adults more choice and better access to services, researchers report.

20 Jan 2014

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).

18 Jan 2014

Persistent insomnia symptom risk high

Insomnia symptoms are often persistent, report researchers who found that targeting sleep-interfering behaviors may be one method of prevention.

13 Jan 2014

Merck announces FDA approval of ISENTRESS for oral suspension

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration recently approved ISENTRESS for oral suspension, a new pediatric formulation of Merck's integrase inhibitor. With this approval, ISENTRESS is now indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients four weeks of age and older.

9 Jan 2014